Graf Akcie PGEN (Precigen, Inc.). Diskuze k akciím PGEN. Aktuální informace PGEN.

Základní informace o společnosti Precigen, Inc. (Akcie PGEN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace
Hodnota podniku (EV)
Tržby
EBITDA
Zisk
Růst v tržbách Q/Q %
Růst v tržbách Y/Y %
P/E (Cena vůči ziskům)
Forward P/E
EV/Sales
EV/EBITDA
EV/EBIT
PEG
Price/Sales
P/FCF
Price/Book
Účetní hodnota na akcii
Hotovost na akcii
FCF vůči ceně %
Počet zaměstnanců
Tržba na zaměstnance
Profit margin %
Operating margin %
Gross margin %
EBIT margin %
EBITDA margin %
EPS - Zisk na akcii
EPS - Kvartální růst %
EPS - Očekávaný růst příští rok %
Return on assets %
Return on equity %
ROIC %
ROCE %
Dluhy/Equity
Čistý dluh/EBITDA
Current ratio
Quick Ratio
Volatilita
Beta
RSI
Cílová cena analytiků
Známka akcie (dle analytiků)
Insider ownership %
Institutional ownership %
Počet akcií
Procento shortovaných akcií %
Short ratio %
Dividenda
Procentuální dividenda %
Dividenda/Zisk %
Obchodovaná od
Země

Finanční výsledky akcie PGEN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$90.722$151.178$219.463$190.926$173.605$71.93
Cost Of Goods Sold$61.401$62.676$61.692$61.639$63.929$19.26
Gross Profit$29.321$88.502$157.771$129.287$109.676$52.67
Research And Development Expenses$101.879$366.248$109.176$112.135$147.483$58.983
SG&A Expenses$100.844$125.751$130.682$142.318$109.057$63.649
Other Operating Income Or Expenses$-30.81-$-13.823---
Operating Expenses$294.934$554.675$315.373$316.092$320.469$141.892
Operating Income$-204.212$-403.497$-95.91$-125.166$-146.864$-69.962
Total Non-Operating Income/Expense$-4.475$-26.245$17.543$-68.985$59.886$-15.757
Pre-Tax Income$-208.687$-429.742$-78.367$-194.151$-86.978$-85.719
Income Taxes$-0.93$-15.425$2.072$-3.877$1.016$-0.103
Income After Taxes$-207.757$-414.317$-80.439$-190.274$-87.994$-85.616
Other Income------
Income From Continuous Operations$-207.757$-414.317$-80.439$-190.274$-87.994$-85.616
Income From Discontinued Operations$-116.159$-100.389$-46.381---
Net Income$-322.324$-509.336$-117.018$-186.612$-84.493$-81.822
EBITDA$-178.695$-336.578$-66.94$-40.63$-195.355$-47.721
EBIT$-204.212$-403.497$-95.91$-125.166$-146.864$-69.962
Basic Shares Outstanding15413012011811199
Shares Outstanding15413012011811199
Basic EPS$-2.09$-3.93$-0.98$-1.58$-0.76$-0.83
EPS - Earnings Per Share$-2.09$-3.93$-0.98$-1.58$-0.76$-0.83
# 2020 2019 2018 2017 2016 2015
Current Ratio1.9094.63731.92143.33154.26593.6808
Long-term Debt / Capital0.72210.3580.01360.01310.01070.0208
Debt/Equity Ratio3.06670.56020.01510.01540.01290.0309
Gross Margin32.319658.541671.889667.715863.175673.224
Operating Margin-225.0964-266.9019-43.7021-65.5573-84.5967-97.264
EBIT Margin-225.0964-266.9019-43.7021-65.5573-84.5967-97.264
EBITDA Margin-196.9698-222.6369-30.5017-21.2805-112.5284-66.3437
Pre-Tax Profit Margin-230.0291-284.2623-35.7085-101.6891-50.1011-119.17
Net Profit Margin-355.2876-336.9115-53.3202-97.7405-48.6697-113.7523
Asset Turnover0.19910.21110.25920.20120.17680.1248
Inventory Turnover Ratio3.81443.04623.01042.91592.40670.7468
Receiveable Turnover3.4595.69095.50854.65843.35842.5909
Days Sales In Receivables105.522664.137866.261678.3525108.6832140.88
ROE - Return On Equity-289.7144-109.3987-14.7177-33.4255-12.4834-20.9182
Return On Tangible Equity344.0312-211.2428-50.1556-102.0466-30.1162-35.3372
ROA - Return On Assets-45.5844-57.8512-9.4986-20.0485-8.9603-14.8569
ROI - Return On Investment-80.516-70.2306-14.5176-32.9873-12.3503-20.4831
Book Value Per Share0.43922.36674.47674.79616.04234.0702
Operating Cash Flow Per Share0.0774-0.0949-0.4491-0.73640.52141.1107
Free Cash Flow Per Share0.1396-0.0232-0.5586-0.8930.47471.0737